S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in
NASDAQ:ACAD

ACADIA Pharmaceuticals Earnings Date, Estimates & History

$48.69
-1.05 (-2.11 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$48.33
Now: $48.69
$50.40
50-Day Range
$46.58
MA: $51.59
$54.99
52-Week Range
$30.02
Now: $48.69
$58.72
Volume996,236 shs
Average Volume892,966 shs
Market Capitalization$7.74 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.44

Earnings

ACADIA Pharmaceuticals (NASDAQ:ACAD) Earnings Information

ACADIA Pharmaceuticals last posted its earnings data on February 23rd, 2021. The biopharmaceutical company reported ($0.42) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.05. ACADIA Pharmaceuticals has generated ($1.60) earnings per share over the last year. ACADIA Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.

ACADIA Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Earnings Estimates

2021 EPS Consensus Estimate: ($0.78)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.37)($0.34)($0.36)
Q2 20212($0.22)($0.21)($0.22)
Q3 20212($0.14)$0.06($0.04)
Q4 20211($0.17)($0.17)($0.17)

ACADIA Pharmaceuticals (NASDAQ ACAD) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/5/2021
(Estimated)
       
2/23/202112/31/2020($0.47)($0.42)Transcript
11/9/20209/30/2020($0.38)($0.54)($0.54)$118.82 million$120.58 millionTranscript
8/5/20206/30/2020($0.44)($0.27)($0.27)$105.65 million$110.10 millionTranscript
5/7/20203/31/2020($0.48)($0.57)($0.57)$90.76 million$90.07 millionTranscript
2/26/2020Q4($0.37)($0.34)($0.34)$95.87 million$98.33 millionTranscript
10/30/2019Q3($0.40)($0.29)($0.29)$88.49 million$94.59 millionTranscript
7/31/2019Q2($0.46)($0.38)($0.38)$72.50 million$83.21 millionN/A
5/1/20193/31/2019($0.54)($0.59)($0.59)$60.93 million$62.90 millionTranscript
2/26/2019Q4 2018($0.55)($0.50)($0.50)$59.46 million$59.57 millionListen
11/6/20189/30/2018($0.58)($0.50)($0.50)$56.31 million$58.31 millionTranscript
8/8/2018Q2 2018($0.45)($0.51)($0.51)$58.63 million$57.06 millionN/A
5/4/20183/31/2018($0.56)($0.44)($0.44)$47.06 million$48.90 millionN/A
2/27/2018Q4 2017($0.58)($0.55)($0.55)$45.30 million$43.56 millionTranscript
11/7/2017Q3 2017($0.63)($0.53)($0.53)$32.03 million$35.58 millionN/A
8/8/2017Q2 2017($0.72)($0.55)($0.55)$20.02 million$30.50 millionListen
5/9/2017Q1 2017($0.7310)($0.72)($0.72)$15.17 million$15.30 millionListen
2/28/2017Q416($0.65)($0.65)($0.65)$9.05 million$12.00 millionListen
11/7/2016Q316($0.56)($0.61)($0.61)$2.90 million$5.30 millionListen
8/4/2016Q216($0.49)($0.63)($0.63)$0.71 million$0.97 millionListen
5/5/2016Q116($0.42)($0.45)($0.45)$0.22 millionListen
2/29/2016Q415($0.38)($0.45)($0.45)$0.02 millionListen
11/5/2015Q315($0.40)($0.39)($0.39)$0.05 million$0.04 millionListen
8/6/2015Q215($0.33)($0.39)($0.39)$0.06 millionListen
5/7/2015Q115($0.25)($0.40)($0.40)$0.09 millionListen
2/26/2015Q414($0.26)($0.28)($0.28)$0.08 million$0.05 millionListen
11/10/2014Q3($0.12)($0.25)($0.25)$0.02 millionListen
8/5/2014Q2($0.17)($0.22)($0.22)$0.10 million$0.03 millionListen
5/6/2014Q1($0.13)($0.19)($0.19)$0.50 million$0.03 millionListen
2/27/2014Q4 2013($0.13)($0.13)($0.13)$0.30 million$0.04 millionListen
11/6/2013Q3 2013($0.12)($0.12)($0.12)$0.25 million$0.24 millionN/A
8/6/2013Q2 2013($0.09)($0.11)($0.11)$0.45 million$451.00 millionListen
5/7/2013Q1 2013($0.08)($0.08)($0.08)$0.45 million$0.42 millionListen
3/12/2013Q4 2012($0.08)($0.11)($0.11)N/A
11/5/2012Q312($0.09)($0.04)$1.90 million$3.50 millionN/A
8/8/2012Q2 2012($0.12)($0.10)($0.10)N/A
5/8/2012Q1 2012($0.11)($0.12)($0.12)N/A
3/6/2012Q4 2011($0.10)($0.10)($0.10)N/A
11/9/2011Q3 2011($0.10)($0.10)($0.10)N/A
8/10/2011Q2 2011($0.15)($0.10)($0.08)N/A
5/10/2011Q1 2011($0.11)($0.12)($0.12)N/A
3/10/2011Q4 2010$0.69$0.74$0.74N/A
11/9/2010Q3 2010($0.17)($0.11)($0.11)N/A
8/9/2010Q2 2010($0.16)($0.11)($0.11)N/A
5/10/2010Q1 2010($0.17)($0.14)($0.14)N/A
3/9/2010Q4 2009($0.19)($0.23)($0.23)N/A
11/9/2009Q3 2009($0.27)($0.23)($0.23)N/A
8/5/2009Q2 2009($0.34)($0.34)($0.34)N/A
5/11/2009Q1 2009($0.36)($0.40)($0.40)N/A
3/9/2009Q4 2008($0.38)($0.38)($0.38)N/A
11/5/2008Q3 2008($0.43)($0.36)($0.30)N/A
8/5/2008Q2 2008($0.46)($0.49)($0.49)N/A
5/5/2008Q1 2008($0.46)($0.44)($0.44)N/A
3/5/2008Q4 2007($0.46)($0.46)($0.46)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.